167 related articles for article (PubMed ID: 34956226)
1. Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation.
Ebbesen M; Kissow H; Hartmann B; Kielsen K; Sørensen K; Stinson SE; Frithioff-Bøjsøe C; Esmann Fonvig C; Holm JC; Hansen T; Holst JJ; Müller KG
Front Immunol; 2021; 12():793588. PubMed ID: 34956226
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation.
Ebbesen MS; Kissow H; Hartmann B; Grell K; Gørløv JS; Kielsen K; Holst JJ; Müller K
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1085-1091. PubMed ID: 30731250
[TBL] [Abstract][Full Text] [Related]
3. Morphine consumption is associated with systemic inflammation in children undergoing allogeneic hematopoietic stem cell transplantation.
De Pietri S; Nielsen BN; Ifversen M; Kielsen K; Müller KG
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):285-291. PubMed ID: 30892107
[No Abstract] [Full Text] [Related]
4. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.
Jordan K; Pontoppidan P; Uhlving HH; Kielsen K; Burrin DG; Weischendorff S; Christensen IJ; Jørgensen MH; Heilmann C; Sengeløv H; Müller K
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1170-1176. PubMed ID: 28344059
[TBL] [Abstract][Full Text] [Related]
5. Reduced Plasma Amino Acid Levels During Allogeneic Hematopoietic Stem Cell Transplantation Are Associated with Systemic Inflammation and Treatment-Related Complications.
Weischendorff S; Kielsen K; Nederby M; Schmidt L; Burrin D; Heilmann C; Ifversen M; Sengeløv H; Mølgaard C; Müller K
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1432-1440. PubMed ID: 30910606
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation.
Skoczeń S; Rej M; Kwiecińska K; Pietrys D; Tomasik PJ; Wójcik M; Strojny W; Dłużniewska A; Klimasz K; Fijorek K; Korostyński M; Piechota M; Balwierz W
BMC Cancer; 2020 Apr; 20(1):306. PubMed ID: 32293354
[TBL] [Abstract][Full Text] [Related]
7. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
Minculescu L; Kornblit BT; Friis LS; Schiødt I; Petersen SL; Andersen NS; Sengeloev H
Biol Blood Marrow Transplant; 2018 Mar; 24(3):600-607. PubMed ID: 29074374
[TBL] [Abstract][Full Text] [Related]
8. Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation.
Pontoppidan PL; Jordan K; Carlsen AL; Uhlving HH; Kielsen K; Christensen M; Ifversen M; Nielsen CH; Sangild P; Heegaard NH; Heilmann C; Sengeløv H; Müller K
Int Immunopharmacol; 2015 Mar; 25(1):180-8. PubMed ID: 25614225
[TBL] [Abstract][Full Text] [Related]
9. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
[TBL] [Abstract][Full Text] [Related]
10. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
12. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning.
Johansson JE; Brune M; Ekman T
Bone Marrow Transplant; 2001 Oct; 28(8):737-42. PubMed ID: 11781624
[TBL] [Abstract][Full Text] [Related]
13. Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
McNeer JL; Kletzel M; Rademaker A; Alford K; O'Day K; Schaefer C; Duerst R; Jacobsohn DA
Biol Blood Marrow Transplant; 2010 Mar; 16(3):350-7. PubMed ID: 20005964
[TBL] [Abstract][Full Text] [Related]
14. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
15. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins.
Vadmand AC; Nissen AA; Mathiesen S; Soerum ME; Gerbek T; Fridh MK; Sørensen K; Hartmann B; Holst JJ; Müller K
J Clin Endocrinol Metab; 2023 Jan; 108(2):453-462. PubMed ID: 36181459
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. [Value of C-reactive protein level on transplantation day in predicting early post-transplant infections and outcomes of allogeneic hematopoietic stem cell transplantation].
Shen K; Liu Q; Sun J; Jiang Q; Zhang Y; Zhou H; Dai M; Xiao M; Wang J; Luo L; Li Q; An H; Hong ZY; Meng L; Yang M; Zhou J; Wang G
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1535-9. PubMed ID: 26607071
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia and myelodysplastic syndrome.
Cao J; Pei R; Lu Y; Zheng Z; Yuan Z; Li D; Zhang P; Liu X; Chen D; Du X; Chen L; Li S; Ye P; Wang T
Curr Res Transl Med; 2023; 71(1):103360. PubMed ID: 36427418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
